Correlation Between CHAR Technologies and Biosyent

Can any of the company-specific risk be diversified away by investing in both CHAR Technologies and Biosyent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CHAR Technologies and Biosyent into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CHAR Technologies and Biosyent, you can compare the effects of market volatilities on CHAR Technologies and Biosyent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CHAR Technologies with a short position of Biosyent. Check out your portfolio center. Please also check ongoing floating volatility patterns of CHAR Technologies and Biosyent.

Diversification Opportunities for CHAR Technologies and Biosyent

-0.54

Correlation Coefficient

CHAR Technologies  Biosyent

Excellent diversification

The 3 months correlation between CHAR and Biosyent is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding CHAR Technologies and Biosyent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biosyent and CHAR Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CHAR Technologies are associated (or correlated) with Biosyent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biosyent has no effect on the direction of CHAR Technologies i.e., CHAR Technologies and Biosyent go up and down completely randomly.

Pair Corralation between CHAR Technologies and Biosyent

Assuming the 90 days horizon CHAR Technologies is expected to generate 2.92 times more return on investment than Biosyent. However, CHAR Technologies is 2.92 times more volatile than Biosyent. It trades about 0.02 of its potential returns per unit of risk. Biosyent is currently generating about -0.02 per unit of risk. If you would invest  21.00  in CHAR Technologies on October 5, 2024 and sell it today you would earn a total of  0.00  from holding CHAR Technologies or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

CHAR Technologies  vs.  Biosyent

CHAR Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CHAR Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Biosyent

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biosyent are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Biosyent is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with CHAR Technologies and Biosyent

The main advantage of trading using opposite CHAR Technologies and Biosyent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CHAR Technologies position performs unexpectedly, Biosyent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biosyent will offset losses from the drop in Biosyent's long position.

The idea behind CHAR Technologies and Biosyent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.